Israel - Hebräisch - Ministry of Health

eliezer linevitz ltd. - ivermectin - פסטה - ivermectin 18.7 mg/g

Israel - Hebräisch - Ministry of Health

linevitz eliezer - ivermectin 18.7 mg/g - paste - control the following horse parasites: large redworms: adult and arterial and 4-th larval ( arterial) stage of strongylus vulgaris adults and 4-th larval (tissue) stages of s. edentatus (adults) of s.eguinus. small redworm: adult and developing immatures (4-th stage larval) of the following species of small stronyles or cyathostomes: triodontophorus spp. (adults) coroncyclus spp. cyathostomum spp. cylococyclus spp. cylicostephanus spp. poteriostomum spp. (ivermectin is not effictive against encysted larval stages of the small strongyles.) pinworms: adult adn immature oxyuris equi. lungworms: adult and immature dictyocaulus arnfieldi. ascarids: adult and immature parascaris equorum. stomach worms: trichostrongylus axei and habronema muscae. intestinal threadworms: strongyloides westeri. cutaneous worms: microfilariae of onchocerca spp. bots: mouth and stomach stages of gasterophilus spp.

Israel - Hebräisch - Ministry of Health

comex ltd - ivermectin 1.87 %w/w - oral paste - for the treatment and control of the following parasites of horses and donkeys:large strongyles: adults and arterial larval stages of strongylus vulgaris, adults and tissue larval stages of s. edentatus, adults of s. equinus and triodontophorus spp. adult and immature small stronyles influding benzimidazole resistant strains: cyathostomum spp, cylicocyclus spp, cyclicodontophorus spp, gyalocephalus spp. adult and immature lungworms: dictyocaulus arnfieldi. adult and immature oxxyuris equi. adult and immature parascaris equorum. adult trichostrongylus axei, habronema muscae and stronyloides westeri.microfilariae of onchocerca spp. oral and gastric stages of bots: gastrophilus spp.

Israel - Hebräisch - Ministry of Health

zoetis israel holding b.v., israel - moxidectin; praziquantel - ג'ל - moxidectin 1.95 %w/w; praziquantel 12.17 %w/w - equest pramox veterinary is indicated for treatment of mixed cestodes and nematodes or arthropods infections, caused by moxidectin and praziquantel sensitive strains of : large strongyles, small strongyles (adults and intraluminal larval stages), ascarids and other species, tapeworm (adults). the egg reappearance period of small strongyles is 90 days. the product is effective against (developing) intramucosal l4 stages of small strongyles. at 8 weeks after treatment, early (hypobiotic) el3 stages of small strongyles are eliminated.

Israel - Hebräisch - Ministry of Health

comex ltd - ivermectin - פסטה - פומי - ivermectin 1.87 %w/w

Israel - Hebräisch - Ministry of Health

tzamal bio-pharma ltd - hepatitis b immunoglobulin - תמיסה להזרקה - hepatitis b immunoglobulin 312 iu/ml - hepatitis b immunoglobulin - hepatitis b immunoglobulin - prevention of hepatitis b recurrence following liver transplantation : hepagam b is indicated for the prevetion of hepatitis b recurrence following liver transplantation in hbsag-positive liver transplant patients. hepagam b should be administered intravenously for this indication.postexposure prophylaxis : hepagam b is indicated for the treatment of acute exposure to blood containing hbsag perinatal exposure of infants born to hbsag-positive mothers sexual exposure to hbsag-positive persons and household exposure to persons with acute hbv infection in the following settings: acute exposure to blood containing hbsag following either parenteral exposure (needlestick bite sharps) direct mucous membrane contact (accidental splash) or oral ingestion (pipetting accident) involving hbsag - positive materials such as blood plasma or serum. perinatal exposure of infants born to hbsag-positive mothers infants born to mothers positive for hbsag with or without hbeag. perinatal exposure of infants born to hbsag-positive

Israel - Hebräisch - Ministry of Health

cts ltd - rotigotine 4 mg / 24 hour - patches - rotigotine - neupro is indicated for the treatment of the signs and symptoms of early-stage idiopathic parkinson's disease as monotherapy (i.e. without levodopa) or in combination with levodopa, i.e. over the course of the disease, through the late stages when the effect of levodopa wears off or becomes inconsistent and fluctuations of the therapeutic effect occur (end of dose or "on-off" fluctuations).

Israel - Hebräisch - Ministry of Health

cts ltd - rotigotine 6 mg / 24 hour - patches - rotigotine - neupro is indicated for the treatment of the signs and symptoms of early-stage idiopathic parkinson's disease as monotherapy (i.e. without levodopa) or in combination with levodopa, i.e. over the course of the disease, through the late stages when the effect of levodopa wears off or becomes inconsistent and fluctuations of the therapeutic effect occur (end of dose or "on-off" fluctuations).

Israel - Hebräisch - Ministry of Health

cts ltd - rotigotine 8 mg / 24 hour - patches - rotigotine - neupro is indicated for the treatment of the signs and symptoms of early-stage idiopathic parkinson's disease as monotherapy (i.e. without levodopa) or in combination with levodopa, i.e. over the course of the disease, through the late stages when the effect of levodopa wears off or becomes inconsistent and fluctuations of the therapeutic effect occur (end of dose or "on-off" fluctuations).

Israel - Hebräisch - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - norepinephrine bitartrate as monohydrate - תמיסה להזרקה - norepinephrine bitartrate as monohydrate 2.0 mg / 1 ml - norepinephrine - norepinephrine - blood pressure control in certain acute hypotensive stages (e.g. pheochromocytomectomy, sympathectomy, poliomyelitis, spinal anesthesia, myocardial infraction, septicemia, blood transfusion and drug reactions). as an adjunct in the treatment of cardiac arrest and profound hypotension.